BTIG Maintains Buy on Progyny, Raises Price Target to $40

Benzinga Newsdesk www.benzinga.com Positive 60.9%

Neg 0% Neu 0% Pos 60.9%

BTIG analyst David Larsen maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $30 to $40.

Comments

No comments yet. Be the first!